% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Delecluse:301495,
author = {S. Delecluse$^*$ and F. Baccianti$^*$ and M. Zala and A.
Steffens$^*$ and C. Drenda$^*$ and D. Judt$^*$ and T.
Holland-Letz$^*$ and R. Poirey$^*$ and P. Sujobert and H.-J.
Delecluse$^*$},
title = {{E}pstein-{B}arr virus induces aberrant {B} cell migration
and diapedesis via {FAK}-dependent chemotaxis pathways.},
journal = {Nature Communications},
volume = {16},
number = {1},
issn = {2041-1723},
address = {[London]},
publisher = {Springer Nature},
reportid = {DKFZ-2025-01037},
pages = {4581},
year = {2025},
note = {#EA:D400#LA:D400#},
abstract = {Infection with the Epstein-Barr virus (EBV) is a major risk
factor for the development of cancer and autoimmune
disorders. The virus enters the body in the pharynx, but EBV
causes disease in distant organs, including the gut and the
brain. Here we show, using in vitro culture and mouse
infection models, that EBV-infected B cells display features
of homing cells. Infected B cells undergo migration
following paracrine CCL4 release and CCR1 induction, while
CCR1 deficiency inhibits migration and, unexpectedly,
proliferation of infected B cells. Furthermore, migrating
EBV-infected B cells undergo CCL4-dependent diapedesis,
induce ICAM-1 on endothelial cells, and disrupt the
integrity of endothelial barriers. Both migration and
diapedesis are regulated by FAK, with FAK inhibition
blocking growth and survival of EBV-transformed B cells, as
well as their spreading to spleen and brain in an animal
model in vivo. Moreover, IL-10 secreted by EBV-infected B
cells attracts and facilitates diapedesis of EBV-negative
CD52highCD11c+ B cells, which have reported autoimmune
properties. Our results thus provide mechanistic insight on
EBV-induced B cell dysregulation, and also hint curbing
migration as a potential target for reducing the
pathogenicity of EBV-infected B cells.},
keywords = {Animals / B-Lymphocytes: virology / B-Lymphocytes:
immunology / B-Lymphocytes: metabolism / Herpesvirus 4,
Human: physiology / Herpesvirus 4, Human: immunology / Mice
/ Humans / Chemotaxis / Epstein-Barr Virus Infections:
immunology / Epstein-Barr Virus Infections: virology /
Epstein-Barr Virus Infections: pathology / Epstein-Barr
Virus Infections: metabolism / Interleukin-10: metabolism /
Cell Movement / Mice, Inbred C57BL / Receptors, CCR1:
metabolism / Receptors, CCR1: genetics / Intercellular
Adhesion Molecule-1: metabolism / Focal Adhesion Kinase 1:
metabolism / Endothelial Cells: metabolism / Mice, Knockout
/ Interleukin-10 (NLM Chemicals) / Receptors, CCR1 (NLM
Chemicals) / Intercellular Adhesion Molecule-1 (NLM
Chemicals) / Focal Adhesion Kinase 1 (NLM Chemicals) / Ptk2
protein, mouse (NLM Chemicals)},
cin = {D400 / C060},
ddc = {500},
cid = {I:(DE-He78)D400-20160331 / I:(DE-He78)C060-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40389409},
doi = {10.1038/s41467-025-59813-z},
url = {https://inrepo02.dkfz.de/record/301495},
}